Literature DB >> 35106736

P2X7Rs: new therapeutic targets for osteoporosis.

Haoyun Huang1, Yu-Mei He2, Miao-Miao Lin2, Yanchao Wang3, Xiaomei Zhang4, Li Liang5, Xueling He6.   

Abstract

Increasing evidence suggests that both the occurrence and progression of osteoporosis are associated with inflammation, especially in primary osteoporosis. The maintenance of skeletal homeostasis is dependent on the complex regulation of bone metabolism. Numerous evidence suggested that purinoceptor networks are essential for bone homeostasis. In this review, the relationship between inflammation and the development of osteoporosis and the role of P2X7 receptor (P2X7R) in regulating the dynamic regulation of bone reconstruction were covered. We also discussed how P2X7R regulates the balance between resorption and bone formation by osteoblasts and reviewed the relevance of P2X7R polymorphisms in skeletal physiology. Finally, we analyzed potential targets of P2X7R for osteoporosis.
© 2022. The Author(s).

Entities:  

Keywords:  Inflammation; Osteoblasts; Osteoclasts; Osteoporosis; P2X7 receptor

Year:  2022        PMID: 35106736     DOI: 10.1007/s11302-021-09836-0

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  98 in total

1.  Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus.

Authors:  Ippei Kanazawa; Toru Yamaguchi; Masahiro Yamamoto; Toshitsugu Sugimoto
Journal:  J Bone Miner Metab       Date:  2010-02-23       Impact factor: 2.626

Review 2.  Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.

Authors:  Pojchong Chotiyarnwong; Eugene V McCloskey
Journal:  Nat Rev Endocrinol       Date:  2020-04-14       Impact factor: 43.330

3.  Osteoporosis Screening in Younger Postmenopausal Women.

Authors:  Carolyn J Crandall; Kristine E Ensrud
Journal:  JAMA       Date:  2020-01-09       Impact factor: 56.272

Review 4.  The P2X7 receptor: A main player in inflammation.

Authors:  Elena Adinolfi; Anna Lisa Giuliani; Elena De Marchi; Anna Pegoraro; Elisa Orioli; Francesco Di Virgilio
Journal:  Biochem Pharmacol       Date:  2017-12-27       Impact factor: 5.858

Review 5.  Bone, inflammation and the bone marrow niche in chronic kidney disease: what do we know?

Authors:  Sandro Mazzaferro; Giuseppe Cianciolo; Antonio De Pascalis; Chiara Guglielmo; Pablo A Urena Torres; Jordi Bover; Lida Tartaglione; Marzia Pasquali; Gaetano La Manna
Journal:  Nephrol Dial Transplant       Date:  2018-12-01       Impact factor: 5.992

Review 6.  Emerging Technologies in Osteoporosis Diagnosis.

Authors:  Kathryn Schultz; Jennifer Moriatis Wolf
Journal:  J Hand Surg Am       Date:  2018-09-01       Impact factor: 2.230

7.  The effects of estrogen deficiency on cortical bone microporosity and mineralization.

Authors:  Divya Sharma; Adriana I Larriera; Paolo E Palacio-Mancheno; Vittorio Gatti; J Christopher Fritton; Timothy G Bromage; Luis Cardoso; Stephen B Doty; Susannah P Fritton
Journal:  Bone       Date:  2018-01-31       Impact factor: 4.398

Review 8.  Role of the purinergic P2X receptors in osteoclast pathophysiology.

Authors:  Niklas Rye Jørgensen
Journal:  Curr Opin Pharmacol       Date:  2019-04-05       Impact factor: 5.547

Review 9.  Cardiovascular disease and osteoporosis.

Authors:  V Baldini; M Mastropasqua; C M Francucci; E D'Erasmo
Journal:  J Endocrinol Invest       Date:  2005       Impact factor: 4.256

Review 10.  Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention.

Authors:  Hennie G Raterman; Irene Em Bultink; Willem F Lems
Journal:  Expert Opin Pharmacother       Date:  2020-07-01       Impact factor: 3.889

View more
  1 in total

1.  Screening of crosstalk and pyroptosis-related genes linking periodontitis and osteoporosis based on bioinformatics and machine learning.

Authors:  Jia Liu; Ding Zhang; Yu Cao; Huichao Zhang; Jianing Li; Jingyu Xu; Ling Yu; Surong Ye; Luyi Yang
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.